Literature DB >> 21686269

RLIP76 (RalBP1): The first piece of the structural puzzle.

Helen R Mott1, Darerca Owen.   

Abstract

RLIP76 (RalBP1) is a multidomain protein that is a downstream effector of the small GTP ases RalA and RalB. As well as the Ral binding domain it contains a RhoGAP domain active against Cdc42 and Rac1. RLIP76 also binds to proteins involved in endocytosis and to R-Ras. We recently solved the structure of the Ral binding domain of RLIP76 and the structure of the complex that it forms with RalB. The structure shows that, unlike the other Ral effectors characterized so far, RLIP76 forms a coiled-coil that interacts with RalB. The RLIP76 Ral binding domain binds to both the switch regions of RalB, which are the parts of the G protein that chance conformation upon nucleotide exchange. Here, we review our structure and discuss how it sheds light on the other functions of RLIP76.

Entities:  

Year:  2010        PMID: 21686269      PMCID: PMC3116601          DOI: 10.4161/sgtp.1.3.14233

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  24 in total

1.  An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1.

Authors:  A Yamaguchi; T Urano; T Goi; L A Feig
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

2.  Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences.

Authors:  S Awasthi; J Z Cheng; S S Singhal; U Pandya; R Sharma; S V Singh; P Zimniak; Y C Awasthi
Journal:  Biochemistry       Date:  2001-04-03       Impact factor: 3.162

3.  Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors.

Authors:  S Nakashima; K Morinaka; S Koyama; M Ikeda; M Kishida; K Okawa; A Iwamatsu; S Kishida; A Kikuchi
Journal:  EMBO J       Date:  1999-07-01       Impact factor: 11.598

4.  POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis.

Authors:  Sushma Yadav; Ewa Zajac; Sharad S Singhal; Jyotsana Singhal; Kenneth Drake; Yogesh C Awasthi; Sanjay Awasthi
Journal:  Biochem Biophys Res Commun       Date:  2005-03-25       Impact factor: 3.575

Review 5.  The guanine nucleotide-binding switch in three dimensions.

Authors:  I R Vetter; A Wittinghofer
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

6.  Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral.

Authors:  M Ikeda; O Ishida; T Hinoi; S Kishida; A Kikuchi
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

7.  Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex.

Authors:  Shuya Fukai; Hugo T Matern; Junutula R Jagath; Richard H Scheller; Axel T Brunger
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

8.  Expression of ral GTPases, their effectors, and activators in human bladder cancer.

Authors:  Steven Christopher Smith; Gary Oxford; Alexander S Baras; Charles Owens; Dmytro Havaleshko; David L Brautigan; Martin K Safo; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2007-07-01       Impact factor: 12.531

9.  Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases.

Authors:  S B Cantor; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.

Authors:  R Brynmor Fenwick; Louise J Campbell; Karthik Rajasekar; Sunil Prasannan; Daniel Nietlispach; Jacques Camonis; Darerca Owen; Helen R Mott
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

View more
  4 in total

Review 1.  Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.

Authors:  Sharad S Singhal; Divya Jain; Preeti Singhal; Sanjay Awasthi; Jyotsana Singhal; David Horne
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-28       Impact factor: 10.680

Review 2.  Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame.

Authors:  Leanna R Gentry; Timothy D Martin; David J Reiner; Channing J Der
Journal:  Biochim Biophys Acta       Date:  2014-09-16

3.  Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.

Authors:  Lawrence E Goldfinger; Seunghyung Lee
Journal:  Lung Cancer (Auckl)       Date:  2013

4.  Differential involvement of RalA and RalB in colorectal cancer.

Authors:  Timothy D Martin; Channing J Der
Journal:  Small GTPases       Date:  2012 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.